{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Hauppauge",
      "address_1": "Suite # 401, 4th Floor",
      "reason_for_recall": "CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.",
      "address_2": "Room No. 430, 150 Motor Parkway",
      "product_quantity": "4,127,500 tablets",
      "code_info": "Lot #: HI6001, HI6002, HI6003, Exp 02/18",
      "center_classification_date": "20180124",
      "distribution_pattern": "Distributed to repackaging firms in NY who then distributed Nationwide in the USA.",
      "state": "NY",
      "product_description": "Ibuprofen Tablets, USP 200 mg, 6 x 6500 Tablets bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403 722, India, NDC 25000-136-20.",
      "report_date": "20180131",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Marksans Pharma Inc.",
      "recall_number": "D-0236-2018",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "78822",
      "termination_date": "20200526",
      "recall_initiation_date": "20180109",
      "postal_code": "11788",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}